Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
238.75
-7.1 (-2.89%)
BSENSE

Dec 05

BSE+NSE Vol: 24.85 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
163.18
172.00
133.45
161.19
131.11
139.41
145.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
163.18
172.00
133.45
161.19
131.11
139.41
145.50
Raw Material Cost
72.78
75.95
60.91
76.82
64.20
66.87
63.85
Purchase of Finished goods
3.10
3.89
4.71
3.20
3.28
3.98
6.51
(Increase) / Decrease In Stocks
-0.54
4.48
-3.75
2.00
-1.22
-0.42
0.47
Employee Cost
28.69
26.42
26.31
26.35
25.15
20.14
24.63
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
0.00
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
34.71
31.64
31.32
32.82
28.73
30.67
28.89
Total Expenditure (Excl Depreciation)
138.75
142.38
119.51
141.19
120.13
121.24
124.35
Operating Profit (PBDIT) excl Other Income
24.43
29.62
13.94
20.00
10.98
18.17
21.15
Other Income
0.35
1.84
0.84
1.63
0.94
0.93
0.69
Operating Profit (PBDIT)
24.78
31.46
14.78
21.63
11.92
19.10
21.84
Interest
7.54
9.04
10.17
10.15
7.59
7.46
8.26
Exceptional Items
0.00
0.00
0.00
0.00
0.00
25.56
0.00
Gross Profit (PBDT)
17.24
22.42
4.61
11.48
4.33
37.20
13.58
Depreciation
3.64
3.37
3.32
3.32
3.29
3.28
3.32
Profit Before Tax
13.61
19.05
1.29
8.17
1.04
33.91
10.26
Tax
0.12
-1.20
0.07
0.15
0.00
0.27
-0.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
13.49
20.26
1.22
8.02
1.04
33.63
10.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
13.49
20.26
1.22
8.02
1.04
33.63
10.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13.49
20.26
1.22
8.02
1.04
33.63
10.27
Equity Capital
32.88
32.77
32.77
32.76
32.75
32.75
32.75
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.1
6.18
0.37
2.45
0.32
10.27
3.14
Diluted Earnings per share
3.95
5.98
0.35
2.34
0.31
10.08
3.13
Operating Profit Margin (Excl OI)
14.97%
17.22%
10.45%
12.41%
8.37%
13.03%
14.54%
Gross Profit Margin
10.57%
13.03%
3.45%
7.12%
3.3%
26.68%
9.33%
PAT Margin
8.27%
11.78%
0.91%
4.98%
0.79%
24.12%
7.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is -1.91% vs -5.13% in Jun 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 12.53% vs -33.42% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 5.53% vs -17.52% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -5.57% vs -16.59% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Wanbury With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
163.18
57.56
105.62
183.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
163.18
57.56
105.62
183.50%
Raw Material Cost
72.78
29.61
43.17
145.80%
Purchase of Finished goods
3.10
0.00
3.10
(Increase) / Decrease In Stocks
-0.54
0.80
-1.34
-167.50%
Employee Cost
28.69
8.34
20.35
244.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
34.71
7.46
27.25
365.28%
Total Expenditure (Excl Depreciation)
138.75
46.21
92.54
200.26%
Operating Profit (PBDIT) excl Other Income
24.43
11.35
13.08
115.24%
Other Income
0.35
1.21
-0.86
-71.07%
Operating Profit (PBDIT)
24.78
12.56
12.22
97.29%
Interest
7.54
1.53
6.01
392.81%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
17.24
11.03
6.21
56.30%
Depreciation
3.64
5.68
-2.04
-35.92%
Profit Before Tax
13.61
5.36
8.25
153.92%
Tax
0.12
0.82
-0.70
-85.37%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.49
4.54
8.95
197.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.49
4.54
8.95
197.14%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.49
4.54
8.95
197.14%
Equity Capital
32.88
22.25
10.63
47.78%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.10
2.04
2.06
100.98%
Diluted Earnings per share
3.95
2.03
1.92
94.58%
Operating Profit Margin (Excl OI)
14.97%
19.72%
0.00
-4.75%
Gross Profit Margin
10.57%
19.16%
0.00
-8.59%
PAT Margin
8.27%
7.89%
0.00
0.38%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 160.06 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -1.91% vs -5.13% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -0.70% vs 11.58% in Sep 2024

Quarterly - Standalone Net Profit
Standalone Net Profit 15.18 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 12.53% vs -33.42% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 89.28% vs 8.97% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.78 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 5.53% vs -17.52% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 28.90% vs 15.34% in Sep 2024

Quarterly - Interest
Interest 7.12 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -5.57% vs -16.59% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -29.85% vs 32.33% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.11%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024